Pierian is a partner in precision medicine, enabling clinicians and medical facilities to advance clinical genomics programs and modernize patient care. We believe in the potential of genomics to transform human health, and are working to ensure that communities anywhere can experience the benefits. With advanced interpretation technology connected to the most comprehensive genomic knowledgebase, Pierian empowers providers with genomic insights to fulfill the promise of precision care.
$30M sweet spot round size
2014
$30M
from 2 investors over 1 rounds
Pierian raised $30M on December 2, 2021
Investors: OrbiMed and + 4 Other investors